ivylifesciencesJul 21, 20221 min readCase ReportCellular Immunotherapy with Immune Killer Cells for Treating a Lung Cancer Patient with Liver MetastasisWebsite Link:https://jmedscindmc.com/article.asp?issn=1011-4564;year=2022;volume=42;issue=3;spage=134;epage=137;aulast=Wang;type=3
Cellular Immunotherapy with Immune Killer Cells for Treating a Lung Cancer Patient with Liver MetastasisWebsite Link:https://jmedscindmc.com/article.asp?issn=1011-4564;year=2022;volume=42;issue=3;spage=134;epage=137;aulast=Wang;type=3
Phase II “Study to Evaluate the Safety and Efficacy of Immune Killer Cells (IKC) in Stage IV Non-smaPhase II Study to Evaluate the Safety and Efficacy of Immune Killer Cells (IKC®) in Stage IV Non-small Cell Lung Cancer (NSCLC) in...
Opmerkingen